Women’s Health & OB/GYN News

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

Polycystic ovary syndrome presents in many forms with many manifestations, which is why providers must work with patients to treat the condition while factoring in their preferences and top concerns.

A higher risk for developing psoriasis was found in subjects who were fed formula as infants compared with those who were breastfed for at least the first 4 months of life, according to a Swedish study.

Three studies published recently indicate that women who undergo heart surgery are less likely to receive guideline-directed care and more likely to have poor outcomes compared with men.

Bloomberg Philanthropies announced that it has donated $1 billion to make Johns Hopkins University’s medical school free for most of its students seeking an MD.

Late last month, members of the U.S. House of Representatives introduced H.R. 8839, the bipartisan Maternal and Infant Syphilis Prevention Act.

Uterine fibroids increase risks for adverse pregnancy and obstetric outcomes with size, not number, tied to breech presentation, postpartum hemorrhage and placenta previa risks, according to a meta-analysis.

Twenty percent of pregnant women reported using CBD-only products during pregnancy despite limited available data on potential adverse outcomes of CBD, according to findings published in Obstetrics & Gynecology.

Like many sports, such as soccer and basketball, financial independence requires simultaneous offense and defense. One of the most important defensive plays a physician must make is buying disability insurance.

CHICAGO — The addition of abemaciclib to fulvestrant extended PFS for patients with advanced breast cancer whose disease progressed on prior cyclin-dependent kinase 4/6 inhibitor therapy, according to data presented at ASCO Annual Meeting.